Acute respiratory distress syndrome - an undercover antisynthetase syndrome: A case report and review of the literature

Clinical and Experimental Rheumatology

Volumn 30, Issue 3, 2012, Pages 424-428

  Bajocchi, Gianluigi ^a   Piro, Roberto ^b   Lombardini, Cristina ^c   Cavazza, Alberto ^d   Facciolongo, Nicola ^b  

^a Unita Operativa di Reumatologia   (Italy)

^b Unità Operativa di Endocrinologia   (Italy)

^c Servizio di Anestesia e Rianimazione   (Italy)

^d Servizio di Anatomia Patologica   (Italy)

Author keywords

Acute; Antisynthetase; Dermatomyosits; Idiopathic inflammatory myopathies; Polymyositis; Respiratory distress syndrome

Indexed keywords

ALKALINE PHOSPHATASE; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CREATINE KINASE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GAMMA GLUTAMYLTRANSFERASE; JO 1 ANTIBODY; LACTATE DEHYDROGENASE; LEVOFLOXACIN; MEROPENEM; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANTISYNTHETASE SYNDROME; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL OXYGEN TENSION; ARTHRALGIA; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; COUGHING; DETERIORATION; DYSPNEA; ENDOTRACHEAL INTUBATION; FEVER; FOLLOW UP; HEADACHE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HUMAN TISSUE; INTENSIVE CARE; LEUKOCYTE COUNT; MALE; ORGANIZING PNEUMONIA; PRIORITY JOURNAL; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY;

ANTIBODIES, ANTINUCLEAR; DERMATOMYOSITIS; HUMANS; MALE; MIDDLE AGED; MYOSITIS; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 84864743934     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Selva-O'callaghan A, Labrador-Horrillo M, Solans-Laque R, Simeon-Aznar CP, Martínez-Gómez X, Vilardelltarrés M: Myositis-specific and myositisassociated antibodies in a series of eightyeight Mediterranean patients with idiopathic inflammatory myopathy. Arthritis Rheum 2006; 55: 791-798.
2. Sordet C, Goetz J, Sibilia J: Contribution of autoantibodies to the diagnosis and nosology of inflammatory muscle disease. Joint Bone Spine 2006; 73: 646-654.
3. Ghirardello A, Zampieri S, Tarricone E, Iaccarino L, Gorza L, Doria A: Cutting edge issues in polymyositis. Clin Rev Allergy Immunol 2011; 41; 179-189.
4. Richards TJ, Eggebeen A, Gibson K, Yousem S, Fuhrman C, Gochuico BR: Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibodypositive interstitial lung disease. Arthritis Rheum 2009; 60: 2183-2192.
5. Marie I, Hachulla E, Chérin P, Dominique S, Hatron PY, Hellot MF: Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum 2002; 47: 614-622.
6. Tillie-Leblond I, Wislez M, Valeyre D et al.: Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset. Thorax 2008; 63: 53-59.
7. Stone KB, Oddis CV, Fertig N et al.: Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy. Arthritis Rheum 2007; 56: 3125-3131.
8. Yousem SA, Gibson K, Kaminski N, Oddis CV, Ascherman DP: The pulmonary histopathologic manifestations of the anti-Jo-1 tRNA synthetase syndrome. Mod Pathol 2010; 23: 874-880.
9. Douglas WW, Tazelaar HD, Hartman TE, Hartman RP, Decker PA, Schroeder DR: Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 2001; 164: 1182-1185.
10. Friedman AW, Targoff IN, Arnett FC: Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis. Semin Arthritis Rheum 1996; 26: 459-467.
11. Tazelaar HD, Viggiano RW, Pickersgill J, Colby TV: Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis 1990; 141: 727-733.
12. Baron F, Ribbens C, Kaye O, Fillet G, Malaise M, Beguin Y: Effective treatment of anti-Jo-1-associated polymyositis with T-cell-depleted autologus peripheral blood stem cell transplantation. Br J Haematol 2000; 110: 330-342.
13. Hengstman GJ, Brouwer R, Egberts WT et al.: Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies. J Neurol 2002; 249: 69-75.
14. Arsura EL, Greenberg AS: Adverse impact of interstitial pulmonary fibrosis on prognosis in polymyositis and dermatomyositis. Semin Arthritis Rheum 1988; 18: 29-37.
15. Fischer A, Swigris JJ, Du Bois RM et al.: Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia. Respir Med 2009; 103: 1719-1724.
16. Clawson K, Oddis CV: Adult respiratory distress syndrome in polymyositis patients with the anti-Jo-1 antibody. Arthritis Rheum 1995; 38: 1519-1523.
17. Tomsic M, Sifrer F: Acute respiratory distress syndrome in a polymyositis patient with the anti-Jo-1 antibody. Wien Klin Wochenschr 2000; 112: 728-731.
18. Jordan Greco AS, Métrailler JC, Dayer E: The antisynthetase syndrome: a cause of rapidly progressive interstitial lung disease. Rev Med Suisse 2007; 3: 2676-2681.
19. Fagedet D, Bernard S, Colombe B et al.: Acute respiratory distress syndrome as the presenting manifestation of an antisynthetase syndrome. Rev Med Interne 2009; 30: 634-636.
20. Guglielmi S, Merz TM, Gugger M, Suter C, Nicod LP: Acute respiratory distress syndrome secondary to antisynthetase syndrome is reversible with tacrolimus. Eur Respir J 2008; 31: 213-217.
21. Polosa R, Di Mauro C, Spampinato B et al.: A patient with antihistidyl-tRNA synthetase positive polymyositis presenting as acute respiratory distress syndrome. J Clin Rheumatol 2008; 14: 219-221.
22. Ghorbel IB, Klii R, Lamloum M et al.: Détresse respiratoire aiguë révélant ub syndrome des synthétases. Rev Med Interne 2009; 30: (S77-S151).